How can this medicine affect other medicines?

When ganciclovir is taken with imipenem/cilastatin there may be an increased risk of seizures. This combination should be avoided. When ganciclovir is taken with zidovudine, there may be a profound reduction in blood cell production by the bone marrow (myelosuppression). Zidovudine should not be taken during the first three weeks of intravenous ganciclovir treatment and, if possible, the use of these two medicines together should be avoided. Ganciclovir may increase the blood level of didanosine. Probenecid slows the removal of ganciclovir from the body and so may increase the blood level of ganciclovir. It is possible that other medicines with similar side effects may have an additive effect with ganciclovir. These combinations should only be used if the benefits outweight the risks. Medicines implicated include: - chemotherapy medicines - dapsone - pentamidine - amphotericin B - co-trimoxazole - nucleoside analogues such as abacavir, didanosine, lamivudine.

Other medicines containing the same active ingredients

Ganciclovir

<<Go To Page 1

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care or attention by a qualified practitioner. The materials in this web site cannot and should not be used as a basis for diagnosis or choice of treatment. Conditions for use



© Copyright 1998 - 2004 NetDoctor.co.uk - All rights reserved